Special care should be exercised when ZANIDIP is used in patient with sick sinus syndrome (if pacemaker is not in situ). Although hemodynamic controlled studies reveals no impairment of ventricular function, care is also required in patients with moderate to severe LV dysfunction. It has been suggested that some short-acting dihydropyridines may be associated with increase cardiovascular risk in patients with ischemic heart disease.
Register or sign in to continue
Asia's one-stop resource for medical news, clinical reference and education
Sign Out
